Scientists from the University of Warwick (United Kingdom) have discovered why a newly found form of cholesterol seems to be ‘ultra-bad’, leading to increased risk of heart disease. The discovery could lead to new treatments to prevent heart disease particularly in people with type 2 diabetes and the elderly. ‘Ultrabad’ cholesterol, known as MGmin-low-density lipoprotein (LDL), which is more common in people with type 2 diabetes and the elderly, appears to be ‘stickier’ than normal LDL. Dr. Naila Rabbani and colleagues found that MGmin-LDL is created by the addition of sugar groups to ‘normal’ LDL – a process called glycation – making LDL smaller and denser. By changing its shape, the sugar groups expose new regions on the surface of the LDL. These exposed regions are more likely to stick to artery walls, helping to build fatty plaques. As fatty plaques grow they narrow arteries – reducing blood flow – and they can eventually rupture, triggering a blood clot that causes a heart attack or stroke. The team urges that: “[Glycation] of LDL forms small, dense LDL with increased atherogenicity that provides a new route to atherogenic LDL and may explain the escalation of cardiovascular risk in diabetes.”
New Deadly Form of Cholesterol Identified
MGmin-low-density lipoprotein (LDL), commonly found in people with type 2 diabetes and the elderly, readily attaches to artery walls and may be a major factor in coronary heart disease.
Naila Rabbani, Lisa Godfrey, Mingzhan Xue, Fozia Shaheen, Michele Geoffrion, Ross Milne, Paul J. Thornalley. “Glycation of LDL by Methylglyoxal Increases Arterial Atherogenicity: A Possible Contributor to Increased Risk of Cardiovascular Disease in Diabetes.” Diabetes, May 26, 2011
RELATED ARTICLES